Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans

Infection and Immunity

Volumn 69, Issue 10, 2001, Pages 6064-6073

  Retini, C ^a   Kozel, T R ^a   Pietrella, D ^a   Monari, C ^a   Bistoni, F ^a   Vecchiarelli, A ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLUCOSE DERIVATIVE; GLUCURONOXYLOMANNAN; INTERLEUKIN 10; INTERLEUKIN 12; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE RELEASE; ENCAPSULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; LEUKOCYTE; LYMPHOCYTE DIFFERENTIATION; MONOCYTE; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; TH1 CELL;

ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, FUNGAL; CELL DIFFERENTIATION; CELLS, CULTURED; CRYPTOCOCCUS NEOFORMANS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MONOCYTES; PHAGOCYTOSIS; POLYSACCHARIDES; T-LYMPHOCYTES;

EID: 0034833393     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.10.6064-6073.2001     Document Type: Article

References (46)

1. Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates
2. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells
3. Role of costimulation in the induction of the IL-12/IL-12 receptor pathway and the development of autoimmunity
4. Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans
5. A galactoxylomannan antigen of Cryptococcus neoformans serotype A
6. Polysaccharide antigens of the capsule of Cryptococcus neoformans
7. Defective induction of IL-12 in human monocytes by germ-tube forms of Candida albicans
8. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome
9. Cytokine treatment of central nervous system infection: Efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis
10. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City
11. Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells
12. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans
13. Interleukin-10
14. Cryptococcal infections in patients with acquired immunodeficiency syndrome
15. Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection
16. Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis
17. Interleukin-12 production by human monocytes infected with Mycobacterium tubercolosis: Role of phagocytosis
18. Comparison of the PREMIER cryptococcal enzyme immunoassay and the latex agglutination assay for detection of cryptococcal antigens
19. CD14-dependent clearance of apoptotic cells: Relevance to the immune system
20. Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon
21. Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive with Cryptococcus neoformans glucuronoxylomannan
22. T cell-dependent activation of macrophages and enhancement of their phagocytic activity in the lungs of mice inoculated with heat-killed Cryptococcus neoformans: Involvement of IFN-γ and its protective effect against cryptococcal infection
23. Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: Effects of IL-12
24. IL-12 protects mice against pulmonary, and disseminated infection caused by Cryptococcus neoformans
25. IL-12 increases CD80 expression and the stimulatory capacity of bone marrow-derived dendritic cells
26. Nonencapsulated variant of Cryptococcus neoformans. II. Surface receptors of cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide
27. Activation of the complement system by pathogenic fungi
28. Influence of opsonization conditions on C3 deposition and phagocyte binding of large and small-capsule Cryptococcus neoformans cells
29. B7-B1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 development pathways: Application to autoimmune disease therapy
30. Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and nonencapsulated Cryptococcus neoformans
31. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis
32. IL-12 induced IL-10 production by human T cells as negative feedback for IL-12-induced immune responses
33. + T cells
34. Early induction of IL-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins
35. Specific activated T cells regulate IL-12 production by human monocytes stimulated with Cryptococcus neoformans
36. Regulation of bioactive IL-12 production in lipolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit
37. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10,IL-12, IFN-γ)
38. Regulation of IL-12 production by human monocytes and the influence of prostaglandin E2
39. Role of alveolar macrophages as antigen presenting cells in Cryptococcus neoformans infection
40. Cryptococcus neoformans differently regulates B7-1 (CD80) and B7-2 (CD86) expression on human monocytes
41. Encapsulation of Cryptococcus neoformans regulates fungicidal activity and antigen presentation process in human alveolar macrophages
42. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes
43. Down-regulation of cryptococcal polysaccharide of tumor necrosis factor-α and interleukin-1β secretion from human monocytes
44. Modulation of anti-Candida activity of human alveolar macrophages by interferon-γ or interleukin-1β
45. Interleukin-10 inhibits antimicrobial activity against Leishmania major in murine macrophages
46. C5a suppresses the production of IL-12 by IFN-γ-primed and lipopolysaccharide-challenged human monocytes